Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes.
about
The changing landscape of hepatitis C virus therapy: focus on interferon-free treatmentBudget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: a multicenter regional simulationPatient-reported Outcomes in Asian Patients With Chronic Hepatitis C Treated With Ledipasvir and Sofosbuvir.Implementation of baby boomer hepatitis C screening and linking to care in gastroenterology practices: a multi-center pilot studyInterferon-free regimens improve health-related quality of life and fatigue in HIV/HCV-coinfected patients with advanced liver disease: A retrospective study.Quality of life of Japanese patients with chronic hepatitis C treated with ledipasvir and sofosbuvir.Update in HIV-hepatitis C virus coinfection in the direct acting antiviral era.Superiority of Interferon-Free Regimens for Chronic Hepatitis C: The Effect on Health-Related Quality of Life and Work Productivity.Patient-reported outcomes with direct-acting antivirals for the treatment of chronic hepatitis C: current knowledge and outstanding issues.Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials.Sofosbuvir and ledipasvir improve patient-reported outcomes in patients co-infected with hepatitis C and human immunodeficiency virus.Association of work productivity with clinical and patient-reported factors in patients infected with hepatitis C virus.In an era of highly effective treatment, hepatitis C screening of the United States general population should be considered.Patient-reported outcomes in patients co-infected with hepatitis C virus and human immunodeficiency virus treated with sofosbuvir and velpatasvir: The ASTRAL-5 study.Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study).Effectiveness of current and future regimens for treating genotype 3 hepatitis C virus infection: a large-scale systematic review.Hepatitis C Virus Infection Is Systemic: Meeting Additional Goals.Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3.
P2860
Q26795559-3167277C-8129-4BE5-B95C-E4293CB5EFCAQ36444618-AAB14951-2EEA-4A9A-A158-1845498E1812Q36663835-B72DE9D5-223B-4593-8A86-5C43E07CFCC8Q36765588-D1360BD9-BF2E-4C0A-83EC-8C78CBF6C28FQ37327979-A0A7335A-AE49-4778-B733-35F459A92877Q37726632-5ED8B82B-A2F2-4A65-9400-9A967DB333FAQ38753617-0C1AF74D-132D-47F3-A2A6-4BB7EC057D05Q38957601-D0A5AC1A-0F62-4044-A653-F7A941103B8CQ39002714-9DF35378-09E2-4B83-9C6F-CEC6EE6EF23AQ39574126-9F827DD5-1F11-426B-B1E3-C6F41321D5C3Q39690321-216EDCFC-5ACC-4867-82E0-44E97E102C42Q39911124-01B1D46E-3AB9-4F4F-B45F-B3B9B0C19647Q40118666-28D2F45C-5C94-4AC0-A2E3-8F237A1BCE5EQ40215825-88F193A4-EF84-4B8A-8461-008E2D00D4F6Q45323675-08BA829D-06CE-474B-9037-B3181466315EQ45324737-4402D087-78D8-4DE9-A751-EE0BA8ECAAC5Q45343583-F3399BE0-DD85-41FF-9F91-11E189599BFCQ47404164-77E6F34B-27B4-41B9-AB9E-C88B107CC698
P2860
Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 January 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sofosbuvir and Ribavirin for T ...... on Patient-Reported Outcomes.
@en
Sofosbuvir and Ribavirin for T ...... on Patient-Reported Outcomes.
@nl
type
label
Sofosbuvir and Ribavirin for T ...... on Patient-Reported Outcomes.
@en
Sofosbuvir and Ribavirin for T ...... on Patient-Reported Outcomes.
@nl
prefLabel
Sofosbuvir and Ribavirin for T ...... on Patient-Reported Outcomes.
@en
Sofosbuvir and Ribavirin for T ...... on Patient-Reported Outcomes.
@nl
P2093
P2860
P356
P1476
Sofosbuvir and Ribavirin for T ...... on Patient-Reported Outcomes.
@en
P2093
Maria Stepanova
Mark Sulkowski
Massimo Puoti
Sharon L Hunt
Susanna Naggie
Zobair M Younossi
P2860
P304
P356
10.1093/INFDIS/JIV005
P407
P50
P577
2015-01-12T00:00:00Z